Match Document Document Title
US20150183705 Oxidation Process For Preparing Purified Aromatic Carboxylic Acids  
A process including: (a) contacting an aqueous solution including a crude aromatic carboxylic acid with an oxygen source in the presence of an oxidation catalyst including at least one of Ru, Au,...
US20110207705 OVIEDOMYCIN DERIVATIVES, METHOD FOR OBTAINING SAME AND USE THEREOF  
Oviedomycin derivatives, method for obtaining same and use thereof. This invention relates to oviedomycin derivatives obtained by fermentation of recombinant bacterial strains. The invention also...
US20140031583 OLEFIN CONDITIONING IN A FAST CATALYTIC PYROLYSIS RECYCLE PROCESS  
This invention relates to improvements in the fast pyrolysis of biomass. In this invention, olefins are separated from the effluent stream of a pyrolysis reactor and at least a portion of the...
US20150051421 PROCESS FOR THE PREPARATION OF METHIONINE  
The invention relates to a process for the preparation of D,L-methionine, in which carbon dioxide is fed to an aqueous potassium methioninate solution obtained by hydrolysis of...
US20110112200 SOLID STATES OF O-DESMETHYLVENLAFAXINE SALTS  
The present invention provides crystalline and amorphous salts of O-desmethylvenlafaxine and processes for preparing said salts of O-desmethylvenlafaxine. The present invention further provides...
US20090299091 PROCESS FOR OBTAINING HIGHLY SOLUBLE LINEAR ALKYLBENZENE SULFONATES  
The present invention relates to a process for obtaining a highly soluble linear alkylbenzene sulfonate with an adjustable 2-phenyl isomer content and an extremely low sulfonation color. In which...
US20130096326 METHOD OF BIOBASED CHEMICAL PRODUCTION FROM CRUDE BIOGLYCERIN  
A method of purification and production of value-added, biobased chemicals and derivative products from crude bioglycerin is described herein. The present method provides methods for desalinating,...
US20110046413 PROCESS FOR PREPARING 4-PENTENOIC ACID  
The present invention relates to a process for preparing 4-pentenoic acid, at least comprising the oxidation of a mixture (G) comprising 4-pentenal, 3-methyl-2-butanone and cyclopentene oxide, and...
US20110245303 HETEROALKYL BIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS  
Described herein are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such...
US20140065075 TARGETED CONTRAST AGENTS AND USES THEREOF  
Described herein is a contrast agent for administration to a subject. The contrast agent includes a targeting portion that includes an unchelated aminocarboxylate functional group; a metal ion...
US20120088932 PROCESS FOR PRODUCING (METH) ACRYLIC ACID  
A process for producing (meth)acrylic acid, comprising the step of repeating a crystallization operation “n” times (providing “n” is an integer 2 or more) to produce purified (meth)acrylic acid...
US20130165687 NOVEL METAL ORGANIC FRAMEWORKS BASED ON ALUMINUM, IRON AND CHROMIUM  
The present invention relates to a porous metal organic framework comprising a bidentate organic compound coordinated to a metal ion selected from the group of metals consisting of Al, Fe and Cr,...
US20090054444 SUBSTITUTED PHENYLACETAMIDES AND THEIR USE AS GLUCOKINASE ACTIVATORS  
Compounds of Formula (I) wherein R1 is a cycloalkylsulphonyl group, or pharmaceutically acceptable salts thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia and...
US20150031911 Post-Gilding of PD-AU-Coated Shell Catalysts  
The invention relates to a method for producing a shell catalyst that is suitable for producing vinyl acetate monomer (VAM). The invention further relates to a shell catalyst that is obtainable by...
US20060264655 Purification of N-(phosphonomethyl)glycine  
The present invention is a process for the purification of glyphosate (PMG) comprising: 1) dissolving or suspending a material comprising PMG in water, in the presence of a base, to produce a...
US20130066106 DRYING AGENT  
One embodiment of the present invention discloses a drying agent having the formula: [Mg2(BTEC)(H2O)m]·nH2O, where m denotes zero or positive integer from 1 to 10, and n denotes zero or positive...
US20140206896 Method and System for Production of Oxalic Acid and Oxalic Acid Reduction Products  
The present disclosure is a method and system for production of oxalic acid and oxalic acid reduction products. The production of oxalic acid and oxalic acid reduction products may include the...
US20140206895 Method and System for Production of Oxalic Acid and Oxalic Acid Reduction Products  
The present disclosure is a method and system for production of oxalic acid and oxalic acid reduction products. The production of oxalic acid and oxalic acid reduction products may include the...
US20140206894 Method and System for Production of Oxalic Acid and Oxalic Acid Reduction Products  
The present disclosure is a method and system for production of oxalic acid and oxalic acid reduction products. The production of oxalic acid and oxalic acid reduction products may include the...
US20100087535 EXTERNAL COMPOSITION FOR SKIN  
A moisturizing agent comprising one or more than one compound selected from the group consisting of lysyl-β-alanine represented by the following general formula (1) and a salt thereof:
US20130245084 CALCIUM-SENSING RECEPTOR-ACTIVE COMPOUNDS  
Compounds of general formula (I) their use as calcium receptor-active compounds for the prophylaxis, treatment or amelioration of physiological disorders or diseases associated with disturbances...
US20130244995 CALCIUM-SENSING RECEPTOR-ACTIVE COMPOUNDS  
Compounds of general formula (I), their use as calcium receptor-active compounds for the prophylaxis, treatment or amelioration of physiological disorders or diseases associated with disturbances...
US20140162996 NOVEL MODULATORS OF DEVELOPMENT OF ADIPOCYTE AND CANCER CELLS  
One aspect of the disclosure relates to derivatives of aryl and heterocyclic ureido aryl and heterocyclic carboxamido isobutyric acids, dichlorophenyl urea, curcumin, and...
US20090305196 DENTAL COMPOSITIONS INCLUDING ORGANOGELATORS, PRODUCTS, AND METHODS  
A hardenable dental composition that includes a polymerizable component and an organogelator.
US20140357877 ACID/SALT SEPARATION  
A method for preparing a carboxylic acid, includes the steps of: providing magnesium carboxylate, wherein the carboxylic acid corresponding with the carboxylate is selected from the group made of...
US20090098169 MODIFIED CLAY MINERAL  
Modified clay minerals obtained by treating a clay mineral with a particular acylarginine derivative are useful for stabilizing emulsion compositions, inter alia, W/O emulsion composition, while...
US20120323038 CARBOXYLATION OF TERMINAL ALKYNES  
The present invention describes a process for converting a terminal alkyne into an alkynoic acid. In this process the alkyne is exposed to carbon dioxide in the presence of a copper (I) species, a...
US20130029923 Materials and Methods for Prevention and Treatment of Viral Infections  
The subject invention provides a novel and advantageous method for preventing and treating viral infection. Specifically exemplified herein are therapeutic uses of forsythoside A and jacaranone,...
US20130058990 COMPOSITION CONTAINING A DIBENZOYLMETHANE SCREENING AGENT AND A HYDROPHILIC OR WATER-SOLUBLE MEROCYANIN UV-SCREENING AGENT; PROCESS FOR PHOTOSTABILIZING THE DIBENZOYLMETHANE SCREENING AGENT  
The present invention relates to a cosmetic composition containing a combination i) of at least one screening agent of the dibenzoylmethane derivative type and ii) of at least one particular...
US20120245384 METHOD OF PREPARING HIGHLY FLUORINATED CARBOXYLIC ACIDS AND THEIR SALTS  
A method for preparing highly fluorinated carboxylic acids and theirs salts and the precursors thereof.
US20090047223 Improvements in or Related to Organic Compoounds  
Malodour counteracting preparations for oral use comprising esterified fumarates of the formula (I) wherein X and Y have the same meaning as given in the description, is disclosed. Furthermore,...
US20110312902 CYTOPROTECTIVE THEREAPEUTIC AGENTS FOR THE PREVENTION OF REPERFUSION INJURY FOLLOWING ISCHEMIC STROKE  
The present invention relates generally to the use of γ-glutamyl antioxidants, particularly γ-glutamyl-cysteine, as cytoprotective agents to prevent reperfusion injury (i.e., hemorrhagic...
US20110044891 High Metal Content Molecular Sieves and Their Manufacture  
A process for manufacturing a synthetic porous crystalline molecular sieve requires an aqueous reaction mixture comprising a source of X2O3 (X is a trivalent element), a source of YO2 (Y is a...
US20080305151 Dipeptide-Comprising Composition for Oral Administration  
The present invention provides a composition for oral administration, which comprises at least one kind of dipeptide represented by the formula: X-Y (wherein X represents alanyl, glycyl, arginyl,...
US20140024715 METHOD AND KIT FOR ADMIINISTERING GAMMA-GLUTAMYL-D-CYSTEINE FOR THE PREVENTION OF REPERFUSION INJURY FOLLOWING ISCHEMIC STROKE  
The present invention provides a method for preventing blood-brain barrier reperfusion injury in a mammalian blood-brain barrier endothelial cell during reperfusion following ischemic stroke...
US20110196040 Skin Penetration Enhancing Systems for Polar Drugs  
The invention relates to pharmaceutical compositions and related methods for the topical administration of polar drugs. In a particular embodiment, the invention relates to a pharmaceutical...
US20120015960 CHEMICAL INHIBITOR OF P53-SNAIL BINDING AND PHARMACEUTICAL COMPOSITION FOR TREATING CANCER DISEASE CONTAINING SAME AS ITS ACTIVE INGREDIENT  
Provided are compounds for inhibiting Snail-p53 binding and therapeutic agents for cancer including the compounds as an effective component. The Snail-p53 binding inhibitors induce expression of...
US20090061528 HPTS-MONO AND BIS CYS-MA POLYMERIZABLE FLUORESCENT DYES FOR USE IN ANALYTE SENSORS  
Novel fluorescent dyes are disclosed for use in analyte detection. In particular, mono- and bis-substituted HPTS dyes and methods of making them are provided.
US20110190227 Antagonists of Prostaglandin D2 Receptors  
Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the compounds described herein that are...
US20110130453 AMINOALKYLPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS  
Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the compounds described herein that are...
US20070197646 SUBSTITUTED TARAXASTANES USEFUL FOR TREATING VIRAL INFECTIONS  
Substituted taraxastanes useful for treating viral infections, are provided herein. Thus, in a first aspect, the invention provides compounds of Formula I and the pharmaceutically acceptable salts...
US20140187637 TROMETHAMINE SALT OF BIMATOPROST ACID IN CRYSTALLINE FORM, METHODS FOR PREPARATION, AND METHODS FOR USE THEREOF  
The present invention provides tromethamine salt of 7-[3,5-Dihydroxy-2-(3-hydroxy-5-phenyl-pent-1-enyl)-cyclopen tyl]-hept-5-enoic acid in crystalline and amorphous form. This compound is may also...
US20150175567 SECONDARY AMINES AS THERAPEUTIC AGENTS  
Compounds such as those represented by Formulas 1-6 can be used in topical liquids, creams, or other dosage forms such as solids, for reducing intraocular pressure, treating glaucoma, growing...
US20120123156 COPRODUCTION OF ACETIC ACID AND ACETIC ANHYDRIDE  
Disclosed is a process for the coproduction of acetic acid and acetic anhydride by producing in a first carbonylation reactor a carbonylation product mixture containing acetic anhydride, removing...
US20110166382 PROCESSES FOR OBTAINING A PHOSPHONIC ACID FROM A PHOSPHONIC ACID ANHYDRIDE  
The present invention relates to a process for recovering a phosphonic acid. The present invention also relates to the conversion of a phosphonic acid to a phosphonic acid anhydride.
US20150240053 POLYSULFIDE ADDITIVE, METHOD FOR PRODUCTION THEREOF AND USE THEREOF IN RUBBER MIXTURES  
The present invention relates to polysulfides of the formula (I) where the cations K1+ and K2+ are each independently any monovalent cation or the fraction of any polyvalent cation which...
US20120123111 Nª -Hydroxy-L-Arginine Derivatives for the Treatment of Diseases  
The present invention relates to physically-chemically and pharmacokinetically enhanced Nω-hydroxy-L-arginine (NOHA) derivatives and a method for producing the NOHA derivatives having enhanced...
US20140243282 METHODS AND COMPOSITIONS FOR DESIGNING NOVEL CONJUGATE THERAPEUTICS  
The present invention relates to novel drug conjugates, where in two drugs are linked together through an appropriate linker having at least two functional groups capable of forming covalent bond...
US20120053244 Alkylamido Compounds and Uses Thereof  
Disclosed herein are compounds that may be specific to PPAR and/or EGF receptors, and methods of making and using same.
US20130196433 Boronate-Mediated Delivery of Molecules into Cells  
Methods for enhancing cellular uptake of cargo molecules by boronating the cargo molecule, particularly with one or more phenylboronic acid groups. Cellular uptake includes at least partial uptake...